Form 10-Q CorMedix Inc. For: Jun 30

Go back to Form 10-Q CorMedix Inc. For: Jun 30

CorMedix (CRMD) Misses Q2 EPS by 2c

August 5, 2016 8:39 AM EDT

CorMedix (NYSE: CRMD) reported Q2 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.51 million, versus $119.97 million reported last year.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

... More